Keyphrases
Antipsychotic-induced Parkinsonism
100%
Haloperidol
38%
Elderly Patients
38%
Drug-induced Parkinsonism
38%
Antipsychotics
23%
Angus
23%
Rating Scales
23%
Quality of Life
15%
Pneumonia
15%
Elderly People
15%
Parkinsonism
15%
Everyday Practices
7%
Healthcare Professionals
7%
Adverse Effects
7%
Polymorphism
7%
Pharmacogenetics
7%
Clinical Practice
7%
Plasma Concentration
7%
High Risk
7%
Cause of Death
7%
Genetic Factors
7%
Pharmacokinetics
7%
Potential Determinants
7%
Genetic Polymorphism
7%
Increasing Risk
7%
Nested Case-control Study
7%
Positive Affect
7%
Mortality in Elderly
7%
Daily Clinical Practice
7%
Treatment Initiation
7%
Duration of Use
7%
Negative Affect
7%
T Allele
7%
Atypical Antipsychotics
7%
Caregivers
7%
Social Functioning
7%
HTR2C Gene
7%
Extrapyramidal Syndrome
7%
Significant Trend
7%
Infectious Pneumonia
7%
DRD2 Gene
7%
DRD3 Gene
7%
QUALIDEM
7%
COMT Gene
7%
ANKK1 Gene
7%
Occurance
7%
RGS2 Gene
7%
Drug-induced Extrapyramidal Symptoms
7%
Symptom Scale
7%
BDNF Gene
7%
HTR2A Gene
7%
Clinimetric Properties
7%
Recommendations for Practice
7%
Pharmacology, Toxicology and Pharmaceutical Science
Antipsychotic
100%
Parkinsonism
100%
4 (para chlorophenyl) 1 [3 (para fluorobenzoyl)propyl] 4 piperidinol
25%
Typical Antipsychotic
15%
Case-Control Study
5%
Pharmacogenetics
5%
Atypical Antipsychotics
5%
Extrapyramidal Syndrome
5%
Pharmacokinetics
5%
Adverse Event
5%
Prevalence
5%
Cross-Sectional Study
5%
Brain Derived Neurotrophic Factor
5%
Extrapyramidal Symptoms
5%
Infectious Pneumonia
5%
Catechol Methyltransferase
5%
Neuroscience
Antipsychotic
100%
Parkinsonism
100%
Haloperidol
25%
Typical Antipsychotic
15%
Brain-Derived Neurotrophic Factor
5%
Pharmacokinetics
5%
Adverse Effect
5%
ANKK1
5%
Catechol Methyltransferase
5%
Genetic Polymorphism
5%
Atypical Antipsychotic
5%
Extrapyramidal Symptoms
5%